DOI QR코드

DOI QR Code

The Residues of Enrofloxacin in Cultured Paralichthys olivaceus

양식산 넙치에서 Enrofloxacin의 잔류

  • Seo, Jung Soo (Pathology Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Jeon, Eun Ji (Pathology Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Lee, Eun Hye (Pathology Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Jung, Sung Hee (Pathology Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Park, Myoung Ae (Aquatic Life Disease Control Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Jee, Bo Young (Aquatic Life Disease Control Division, National Fisheries Research & Development Institute (NFRDI)) ;
  • Kim, Na Young (Aquatic Life Disease Control Division, National Fisheries Research & Development Institute (NFRDI))
  • 서정수 (국립수산과학원 병리연구과) ;
  • 전은지 (국립수산과학원 병리연구과) ;
  • 이은혜 (국립수산과학원 병리연구과) ;
  • 정승희 (국립수산과학원 병리연구과) ;
  • 박명애 (국립수산과학원 수산생물방역과) ;
  • 지보영 (국립수산과학원 수산생물방역과) ;
  • 김나영 (국립수산과학원 수산생물방역과)
  • Received : 2012.12.21
  • Accepted : 2013.04.08
  • Published : 2013.04.30

Abstract

Enrofloxacin is one of the normally used flouroquinolones in mammalian and fish but its withdrawal time and studies were remain obscure. The residual contents of enrofloxacin in fish muscle were analyzed by using HPLC-FLD. More than 0.1 mg/kg of ENR was detected in muscle tissues and the residues were found over 1 year after treatment. The concentration of ENR in Paralichthys olivaceus was not affected by water temperature and lasted for an extended amount of time. The spike recoveries of ENR in the muscle tissue ranged from 78% to 85%. From this results, we need the prescription by veterinarian or aquatic organism disease inspector in ENR usage to assure safety of fish. Future research is required to determine the recommendation dose of ENR for side effects and safety.

Keywords

References

  1. Bowser, P. R., Wooster, G. A., Stleger, J. and Babish, J. G.: Phamacokinetics of enrofloxacin in fingerling rainbow trout(Oncorhynchus mykiss), J. Vet. Phamacol. Therap., 15:62-71, 1992. https://doi.org/10.1111/j.1365-2885.1992.tb00987.x
  2. Brown, S. A.: Fluoroquinolones in animal health, J. Vet. Phamacol. Therap., 19:1-14, 1996. https://doi.org/10.1111/j.1365-2885.1996.tb00001.x
  3. Herikstad, H., Hayers, P., Mokhtar, M., Fracaro, M. L., Threlfall, E. J. and Angulo, F. J.: Emerging quinolone-resistant Salmonella in the USA. Emerg. Infect. Dis., 3:371-372, 1997. https://doi.org/10.3201/eid0303.970316
  4. Horie, M., Saito, K., Nose, N. and Nakazawa, H.: Determination of enrofloxacin in meat and fish by high performance liquid chromatography. J. Food. Hyg. Soc. Japan., 34:289-293, 1993. https://doi.org/10.3358/shokueishi.34.289
  5. Lewbart, G., Vaden, S., Deen, J., Manaugh, C., Whitt, D., Doi, A., Smith, T. and Flammer, K.: Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration. J. Vet. Pharmacol. Ther., 20: 124-128, 1997. https://doi.org/10.1046/j.1365-2885.1997.00814.x
  6. Lucchetti, D., Fabrizi, L., Guandalini, E., Podesta, E., Marvasi, L., Zaghini, A. and Coni, E.: Long depletion time of enrofloxacin in rainbow trout (Oncorhynchus mykiss). Antimicrob. Agent Chemother., 48: 3912-3917, 2004. https://doi.org/10.1128/AAC.48.10.3912-3917.2004
  7. Mark, A. M.: Enrofloxacin. J. Exct. Pet. Med., 15:66-90, 2006. https://doi.org/10.1053/j.jepm.2005.11.011
  8. Neer, T. M.: Clinical pharmacologic features of fluoroquinolne antimicrobial drugs.J. American Vet. Med. Assoc., 193:577-580, 1988.
  9. Rocca, D. G., Salvo, A. D., Malvisi, J. and Sello, M.: The disposition of enrofloxacin in seabream (Sprus aurata L.) after single intravenous injection of from medicated feed administration. Aquaculture, 232:53-62, 2004. https://doi.org/10.1016/S0044-8486(03)00455-1
  10. Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A. and Osterholm, M. T.: Quinolone-resistant Campylobacter jejuni infections in Minnesota. New Engl. J. Med., 340:1525-1532, 2003.
  11. Stoffregen, D. A., Wooster, G. A., Bustos, P. S., Bowser, P. R. and Babish, J. G.: Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. J. Vet. Pharmacol. Therap., 20:111-123, 1997. https://doi.org/10.1046/j.1365-2885.1997.81531.x
  12. Treves-Brown K. M.: Applied fish pharmacology, pp.1-117, Kluwer academic publishers, Dordrecht, The Netherlands, 2000.
  13. Vancutsem, P. M., Babish, J. G. and Schwark, W. S.: The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity, Cornell. Vet., 80:173-186, 1990.
  14. Wolfson, J. S. and Hooper, D. C.: The fluoroquinolones: Structure, mechanisms of action and resistance, and spectra of activity invitro.Antimicrob Agents Chemother., 28:581-586, 1985. https://doi.org/10.1128/AAC.28.4.581
  15. 김풍호, 이희정, 조미라, 이태식, 하진환: 양식넙치 (Paralichthys olivaceus)의 enrofloxacin 휴약기간. 한국수산과학회지, 39:72-77, 2006.
  16. 박명애, 육동현, 김수언, 김진아, 박애숙, 김연천, 김무상: 어류 중 fluoroquinolone계 항균제의 분석 및 잔류량 조사. 한국식품과학회지, 44:293-299, 2012.
  17. 조미라: 양식어류에 투여된 퀴놀론계 항균물질의 분석 및 약물동태학적 연구, 경성대학교 식품공학과 박사학위 논문, 1-112, 2003.
  18. 식품공전, 10-5-89, 식품의약품안전청, 2011.

Cited by

  1. 인천 유통 수산물 중 잔류동물용의약품 조사 vol.44, pp.5, 2018, https://doi.org/10.5668/jehs.2018.44.5.444